These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 184427)
1. [Spastic flexion disorders: clinical and metabolic problems observed during treatment with zinc tetracosactide]. Cret L; David M; Macabéo V; Frédérich A; Jeune M Pediatrie; 1976; 31(1):33-48. PubMed ID: 184427 [No Abstract] [Full Text] [Related]
2. [Metabolic disorders induced by a combination of sodium gamma-hydroxybutyrate and tetracosactide in head-injury patients]. Béal JL; Freysz M; Honnart D; Wilkening M Therapie; 1983; 38(5):569-71. PubMed ID: 6322376 [No Abstract] [Full Text] [Related]
3. [Tetracosactide in the treatment of rheumatoid arthritis and gout]. Usobiaga JL Rev Esp Reum Enferm Osteoartic; 1975; 18(2):145-54. PubMed ID: 167406 [No Abstract] [Full Text] [Related]
4. [Hypersensitivity to tetracosactide]. Ligumski M; Kletter-Chemo D; Penchas S Harefuah; 1977 Feb; 92(4):169-70. PubMed ID: 191336 [No Abstract] [Full Text] [Related]
5. [Adverse effects of synthetic ACTH (tetracosactide-Zn)--asthmatic attack and shock-report of 2 cases]. Kawai M; Maekawa N Nihon Kyobu Shikkan Gakkai Zasshi; 1975 Nov; 13(11):663-70. PubMed ID: 176495 [No Abstract] [Full Text] [Related]
7. [Tetracosactide in the acute phase of cerebrovascular accidents]. Cornaert P Lille Med; 1980; 25(7):384-6. PubMed ID: 6253756 [No Abstract] [Full Text] [Related]
8. Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity. Glass D; Roffe L; Maini RN; Wraith DG; Nuki G Clin Exp Immunol; 1975 Apr; 20(1):55-63. PubMed ID: 173487 [TBL] [Abstract][Full Text] [Related]
9. [Discussion of a case of dyschromia]. Nicolay M; Piot V Arch Belg Dermatol; 1974; 30(2):99-101. PubMed ID: 4377809 [No Abstract] [Full Text] [Related]
10. [Synacthene-Retard in mental confusion of aged patients]. Porte M; Juttner G; Michelangeli J; Krebs BP; Lavagna J; Capdeville C; Darcourt G Ann Med Psychol (Paris); 1979; 137(5):481-90. PubMed ID: 228577 [No Abstract] [Full Text] [Related]
11. [Experiences with depot-ACTH (Tetracosactide) in bronchial obstruction]. Kropp R Fortschr Med; 1976 Mar; 94(7):395-8. PubMed ID: 184022 [TBL] [Abstract][Full Text] [Related]
12. [Severe bronchial obstruction as a reaction to the administration of the tetracosactides depot-Cortrosyn and depot-Synacthen]. Roldaan AC; de Jong C Ned Tijdschr Geneeskd; 1981 Feb; 125(8):321-3. PubMed ID: 6261167 [No Abstract] [Full Text] [Related]
13. [Fatal complication of intravenous administration of synthetic adrenocorticotrophin]. Müller M; Fehm HL; Homoki J; Teller WM Dtsch Med Wochenschr; 1982 Sep; 107(36):1353-6. PubMed ID: 6288339 [TBL] [Abstract][Full Text] [Related]